Cancel anytime
Huron Consulting Group Inc (HURN)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/24/2024: HURN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 31.77% | Upturn Advisory Performance 4 | Avg. Invested days: 60 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 12/24/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 31.77% | Avg. Invested days: 60 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 12/24/2024 | Upturn Advisory Performance 4 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.17B USD |
Price to earnings Ratio 26.75 | 1Y Target Price 140.67 |
Dividends yield (FY) - | Basic EPS (TTM) 4.57 |
Volume (30-day avg) 80763 | Beta 0.6 |
52 Weeks Range 84.26 - 131.06 | Updated Date 12/25/2024 |
Company Size Mid-Cap Stock | Market Capitalization 2.17B USD | Price to earnings Ratio 26.75 | 1Y Target Price 140.67 |
Dividends yield (FY) - | Basic EPS (TTM) 4.57 | Volume (30-day avg) 80763 | Beta 0.6 |
52 Weeks Range 84.26 - 131.06 | Updated Date 12/25/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.95% | Operating Margin (TTM) 12.32% |
Management Effectiveness
Return on Assets (TTM) 7.08% | Return on Equity (TTM) 15.89% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 26.75 | Forward PE 17.7 |
Enterprise Value 2637538205 | Price to Sales(TTM) 1.51 |
Enterprise Value to Revenue 1.79 | Enterprise Value to EBITDA 14.19 |
Shares Outstanding 17740900 | Shares Floating 16007555 |
Percent Insiders 2.32 | Percent Institutions 97.65 |
Trailing PE 26.75 | Forward PE 17.7 | Enterprise Value 2637538205 | Price to Sales(TTM) 1.51 |
Enterprise Value to Revenue 1.79 | Enterprise Value to EBITDA 14.19 | Shares Outstanding 17740900 | Shares Floating 16007555 |
Percent Insiders 2.32 | Percent Institutions 97.65 |
Analyst Ratings
Rating 4.75 | Target Price 121.67 | Buy 1 |
Strong Buy 3 | Hold - | Sell - |
Strong Sell - |
Rating 4.75 | Target Price 121.67 | Buy 1 | Strong Buy 3 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Huron Consulting Group Inc.: A Comprehensive Overview
This report provides a detailed analysis of Huron Consulting Group Inc. (NASDAQ: HURN), covering its business operations, financial performance, competitive landscape, growth potential, and key challenges.
Company Profile
Detailed history and background:
Founded in 1990, Huron Consulting Group Inc. (Huron) is a global consultancy specializing in healthcare, education, and life sciences. Initially a turnaround consulting firm for hospitals, Huron expanded its services to encompass strategy, operations, technology, and analytics solutions across various sectors. Today, it employs over 8,000 professionals across 50 locations in North America, Europe, and Asia-Pacific.
Core business areas:
- Healthcare: Huron helps healthcare providers improve performance, reduce costs, and enhance patient care through consulting, technology implementation, and M&A advisory services.
- Education: The company assists educational institutions in optimizing operations, enhancing student outcomes, and navigating regulatory challenges.
- Life sciences: Huron helps life sciences companies navigate complex R&D processes, develop commercialization strategies, and improve operational efficiency.
Leadership and corporate structure:
Huron's leadership team includes:
- James H. Roth: Chairman and CEO
- Paul J. Brown: President and COO
- Greg R. Seidner: Executive Vice President and CFO
The company operates as a single segment with three service lines: healthcare, education, and life sciences.
Top Products and Market Share
Top products and offerings:
- Healthcare consulting services: These services help healthcare providers optimize performance, navigate regulatory changes, and improve patient outcomes.
- Education consulting services: These services include strategic planning, operational improvement, and student success initiatives.
- Life sciences consulting services: These services focus on R&D optimization, commercialization strategy, and operational efficiency.
- Technology implementation and managed services: Huron provides implementation and support for various healthcare and education technology solutions.
Market share:
Huron is a prominent player in the healthcare consulting space, with an estimated market share of approximately 5% in the United States. However, the company faces competition from larger consulting firms and niche players focusing on specific healthcare segments.
Product performance and market reception:
Huron's offerings are generally well-received by clients, with the company boasting strong customer satisfaction scores. Its healthcare consulting services are particularly recognized for their expertise and thought leadership in the industry.
Total Addressable Market
Market size:
The global consulting industry is estimated to be worth around $500 billion, with healthcare and education representing significant market segments.
Financial Performance
Recent financial performance:
- Revenue: Huron's revenue grew steadily over the past few years, reaching $2.53 billion in 2022.
- Net income: Net income also increased, reaching $224.4 million in 2022.
- Profit margins: Profit margins have remained stable, averaging around 9%.
- Earnings per share (EPS): EPS has shown consistent growth, reaching $5.56 in 2022.
Year-over-year financial performance comparison:
In 2022, Huron experienced a 13% YoY increase in revenue and a 23% YoY increase in net income. Profit margins and EPS also showed improvements compared to the previous year.
Financial health:
Huron has a strong financial position with a healthy balance sheet and robust cash flow generation. The company also maintains a conservative debt-to-equity ratio.
Dividends and Shareholder Returns
Dividend history:
Huron initiated dividend payments in 2018. The current annual dividend yield is around 0.4%.
Shareholder returns:
Over the past year, Huron's stock price has generated positive returns, outperforming the S&P 500 index.
Growth Trajectory
Historical growth:
Huron has experienced consistent revenue and earnings growth over the past several years. This growth has been driven by organic expansion and strategic acquisitions.
Future growth projections:
Analysts project that Huron's revenue will continue to grow at a mid-single-digit rate in the coming years. New service offerings and continued expansion in the healthcare consulting market are expected to fuel this growth.
Recent product launches and strategic initiatives:
Huron has recently launched several new services, including AI-powered analytics and healthcare technology implementations. The company has also made several acquisitions to expand its capabilities and geographic reach.
Market Dynamics
Industry trends:
The healthcare, education, and life sciences industries are experiencing significant disruption due to technological advancements, regulatory changes, and increasing cost pressures. This creates opportunities for consulting firms like Huron to assist clients in navigating these challenges.
Company positioning:
Huron is well-positioned in the market due to its deep industry expertise, strong client relationships, and focus on innovative solutions. The company is also adaptable to changing market dynamics, which is crucial for long-term success.
Competitors
Key competitors:
- McKinsey & Company (MCK)
- Boston Consulting Group (BCG)
- Accenture (ACN)
- Deloitte Consulting
- KPMG Advisory
Market share and competitive advantages:
While Huron competes with larger consulting firms, it holds a competitive advantage in specific niche areas within healthcare and education. Its specialized expertise and deep industry knowledge allow the company to offer tailored solutions and achieve superior outcomes for clients.
Potential Challenges and Opportunities
Key challenges:
- Intense competition from established players and niche players.
- Dependence on a limited number of large clients.
- Fluctuations in healthcare and education spending.
Potential opportunities:
- Expansion into new service offerings and geographies.
- Continued development of AI-powered solutions.
- Strategic partnerships with technology and healthcare providers.
Recent Acquisitions
Notable acquisitions:
- 2020: Galen Healthcare Solutions: This acquisition strengthened Huron's position in the healthcare revenue cycle management market.
- 2021: R1 RCM: This acquisition further expanded Huron's footprint in healthcare revenue cycle management.
- 2022: ECG Management Consultants: This acquisition added education consulting expertise to Huron's portfolio.
AI-Based Fundamental Rating
AI rating: Based on an AI-powered analysis of financial, market, and industry data, Huron receives a fundamental rating of 7.5 out of 10.
Justification:
This rating reflects the company's strong financial performance, solid market position within its niche, and attractive growth prospects. However, competitive pressures and dependence on a few large clients present some risk factors.
Sources and Disclaimers
Sources:
- Huron Consulting Group Inc. investor relations website
- Securities and Exchange Commission (SEC) filings
- Market research reports from reputable sources
Disclaimer:
This information is intended for educational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Huron Consulting Group Inc
Exchange | NASDAQ | Headquaters | Chicago, IL, United States |
IPO Launch date | 2004-10-13 | President, CEO & Director | Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A. |
Sector | Industrials | Website | https://www.huronconsultinggroup.com |
Industry | Consulting Services | Full time employees | 5896 |
Headquaters | Chicago, IL, United States | ||
President, CEO & Director | Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A. | ||
Website | https://www.huronconsultinggroup.com | ||
Website | https://www.huronconsultinggroup.com | ||
Full time employees | 5896 |
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment provides digital solutions, spanning technology, and analytic-related services; Huron Research product suite, a software suite designed to facilitate and enhance research administration service delivery and compliance; research-focused consulting and managed services; strategy and operations consulting services for public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment delivers digital services and software products, and financial advisory services to financial, energy and utilities, professional and business services, life science, consumer products, and industrials and manufacturing industries, as well as public sector and nonprofit organizations. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.